In previous studies a subset of complement-component-C3 (C3) epitopes, C3(D), expressed in denatured and surfacebound C3 and C3 fragments, has been described. These epitopes were detected by antibodies raised against denatured C3. In the present study we used a cDNA expression strategy to localize epitopes recognized by monoclonal and polyclonal anti-C3(D) antibodies. First, DNAase I digestion of C3 cDNA was used to generate 200-300 bp fragments. These cDNA fragments were expressed as ,-galactosidase-C3 fusion proteins using the Agtl 1 vector. The fusion proteins were tested by Western-blot analysis for reactivity with monoclonal and polyclonal anti-C3 antibodies, and the location of the epitopes were determined by sequencing the cDNA fragments. Affinity-purified polyclonal anti-C3(D) antibodies specific for denatured C3 reacted strongly with the C3 fusion fragments corresponding to segments of the 40 kDa subunit of C3c (residues 1477-15 10) and the C3d fragment (residues 1117-1155 and 1234-1294) of C3. Adsorption of the polyclonal antibodies with a mixture of EAC3b and EAC3bi (degradation fragments of C3 bound to sheep erythrocytes) abolished binding to fusion proteins spanning the C3d region, but not the 40 kDa fragment of C3c. No effect was seen with the corresponding soluble C3 fragments. The monoclonal anti-C3(D) antibodies (mAbs) 7D326.1 and 7D33 1
INTRODUCTION
Complement component C3 comprises two polypeptide chains (110 kDa and 75 kDa) linked by one disulphide bond and noncovalent forces (Matsuda et al., 1985; Janatova, 1986) . Cleavage of C3 between residues Arg726 and Ser727 of the ac-chain, by either the classical-or the alternative-pathway C3 convertase, generates the C3a and the C3b fragments. The nascent C3b molecule can bind to target molecules by either an ester or an amide bond (Law et al., 1980; Gadd & Reid, 1981) . The cleavage of the cc'-chain of C3b by Factor I, first between residues Arg1281 and Ser'282 and secondly between residues Arg 298 and Ser'299, liberates the 2 kDa C3f fragment and yields iC3b (Lachmann et al., 1982) . Further Factor I cleavages, essentially between residues Arg932 and Glu933, generate the C3d,g fragment with the concomitant liberation of C3c (Medof et al., 1982; Ross et al., 1982; .
The exposure of binding sites for complement components and complement receptors on the different C3 fragments is the result of a series of conformational changes that occurs in the molecule upon transition from one form to another during the proteolytic activation/inactivation. These changes have been detected by both spectroscopic and solution scattering analyses of soluble C3 fragments (Molenaar et al., 1975; Isenman & Cooper, 1981; Isenman, 1983; Perkins & Sim, 1986) and by monoclonal antibodies against neoantigens exposed specifically by C3 fragments . Besides the conformational changes that have been observed during the degradation of fluidphase C3 and its soluble fragments, further conformational changes occur when the C3 fragments bind to target surfaces. These changes are evident from the ability of C3 binding proteins to bind with higher affinity to surface-bound compared with fluid-phase C3 fragments (DiScipio, 1981; Pangburn & MullerEberhard, 1983 ; Ross & Medof, 1985; Becherer & Lambris, 1988) and from exposure of neoantigenic epitopes detected by monoclonal and polyclonal antibodies specific for bound C3 fragments (Nilsson & Nilsson, 1982; Aguado et al., 1985; Nilsson et al., 1987; Alsenz et al., 1990) .
Although much work has been directed toward understanding the structural features involved in the different functions of C3 Lambris, 1988) , comparatively little attention has been given to the conformational changes occurring upon activation/inactivation of C3 and to the specific regions involved in these changes. In the present study we prepared monoclonal (mAb) and polyclonal antibodies with the specificity for a subset of C3 epitopes, C3(D), which are expressed on (a) surface-bound, but not fluid-phase fragments of C3 and/or (b) denatured, but not native, C3 fragments (Nilsson et al., 1980;  Nilsson & Nilsson, 1982 & Nilsson, , 1985 & Nilsson, , 1986 . We determined the location of the recognized epitopes on C3 by generating cDNA fragments encoding different regions of the a-chain of C3 and 
Complement components
Human C3 was purified as described by Hammer et al. (1981) . Factor I (Fearon & Austen, 1977) and Factor H (Nilsson et al., 1975) were isolated from serum as previously described.
C3b was generated by incubating purified C3 with 1 % (w/w) trypsin for 2 min at room temperature (Nilsson et al., 1975) , followed by separation on a Sephadex G-100 column (2.5 cm x 80 cm) equilibrated with saline (0.9 % NaCl) buffered with 25 mM-sodium phosphate, pH 7.4 (PBS). iC3b was produced by incubating C3b (1 mg/ml) with Factor I (33 ,g/ml) and Factor H (170 ,tg/ml) for 60 min at 37 'C. C3c and C3d were generated by incubating C3 with 2 % trypsin for 60 min at 37 'C as described by Eggertsen et al. (1985) .
C3 was labelled with 1251 by using Enzymobeads according to the manufacturer's recommendation (Nilsson & Nilsson, 1985) . C3 retained haemolytic activity after the labelling procedure as determined by haemolytic titration using a C3-depleted serum (Nilsson & Nilsson, 1984) .
Preparation of erythrocytes coated with C3 fragments EAC14OXY23b (EAC3b) and EAC14OXY23bi (EAC3bi) were prepared as previously described (Nilsson & Nilsson, 1985) . The binding of C3 fragments to the cells was calculated by using 1251_ labelled native C3 (Nilsson & Nilsson, 1985) .
Antibody preparations (a) mAbs. mAbs were raised in female BALB/c mice against SDS-denatured-reduced C3 as previously described (Nilsson et al., 1987) .
The mAbs were affinity-purified on Protein A-Sepharose. Culture supernatants containing mAbs were adjusted to 1.5 Mglycine/3 M-NaCl, pH 8.9, and were applied to a 4 ml Protein A-Sepharose column. After washing, the antibodies were eluted with 0.1 M-glycine, pH 2.8, and then dialysed against PBS. The antibodies were designated 4SD 1.1, 4SD1 8.1, 7D9.2, 7D326.1 and 7D331.1.
(b) Preparation of polyclonal anti-C3 antibodies. Antisera against the intact a-chain of human C3, isolated by gel chromatography, and against ovalbumin, were produced as previously described (Nilsson & Nilsson, 1982) . Antibodies specific for the C3d fragment and 40 kDa C-terminal a-chain portion of C3c were generated by immunizing rabbits with the corresponding fragments which had been separated by SDS/PAGE and eluted as previously described (Lambris et al., 1984) .
In order to diminish unspecific binding to Escherichia coliderived proteins, all antisera were affinity-purified by chromatography on a C3-or ovalbumin-Sepharose column containing 5 mg of protein/ml of Sepharose. In the case of the anti-C3 a-chain antiserum, the bound C3 was denatured with SDS before purification. The columns were extensively washed with PBS and the bound proteins eluted with 0.2 M-glycine, pH 2.8. The eluates were dialysed against PBS.
The polyclonal-antibody preparation specific for the x-chain of C3 and the mAbs were all of C3(D) specificity, i.e. the antibodies reacted with SDS-denatured C3 or C3 fragments, but not with native C3, as described by Nilsson & Nilsson (1982 , and Nilsson et al. (1987) respectively.
E.l.i.s.a. for detecting binding of anti-C3 antibodies to C3 fragments
For the assessment of the specificity of mAbs and polyclonal antibodies to fluid-phase C3 fragments, an inhibition e.l.i.s.a. was used. Microtitre plates were coated with 200,l of C3 (3 jug/ml) overnight at 4°C and after that saturated with I % (w/v) BSA. C3 deposited on polystyrene under these conditions adopts a highly denatured conformation, as shown by reactivity with antibodies raised against C3(D) epitopes (Elwing et al., 1988) .
A 50,tl portion of serially diluted test antigen was preincubated with 50,l of a constant amount of monoclonal anti-C3 antibody (0.5-1 ,ug/ml) for 60 min at room temperature in non-treated microtitre plates. After centrifugation, 100,l of supernatant was transferred to the coated microtitre plates and incubated for 60 min at room temperature. The binding of mAb and polyclonal antibody was detected by anti-mouse or anti-rabbit immunoglobulins conjugated with HRP. Under these conditions, DNAase will make double-strand scissions (Crouse et al., 1982) . The digestion was calibrated thus that the mass average size of the digested fragments was about 200 bp. These fragments were electrophoresed through 1.50% agarose and the fragments between 200 and 300 bp were recovered by electroelution. An analytical gel of these fragments showed that there was still some (approx. 5 %) fragments larger than 300 bp. The ends of these fragments were rendered blunt with the large fragment of DNA polymerase I in the presence of the four deoxynucleotides. [a-32P]dCTP was added to lightly label the fragments and monitor them through subsequent steps. The fragments were methylated with EcoRI methylase and ligated to phosphorylated EcoRI linker 10-mers. Then they were digested with EcoRI and separated from excess linkers on Bio-Gel Al 5m. The fractions containing radioactivity were recovered by ethanolprecipitation, ligated to EcoRI-digested, dephosphorylated gtl 1 arms (Grossberger, 1987) , and packaged in Gigapack packaging extracts. The packagings were amplified in the E. coli strain Y1088 (Vogelstein & Gillespie, 1979) , and the amplified lysates were used for screening with either antibody (Grossberger et al., 1989) or DNA probes (Benton & Davis, 1977) .
Screening of the C3 cDNA minilibrary with anti-C3 antibodies Screening was done directly on the library essentially as described by Grossberger et al. (1989) . Affinity-purified polyclonal-antibody preparations against both the C3d fragment and the 40 kDa a-chain subunit of C3c were used to screen the library initially.
After incubation with the primary antibody, the filters were incubated successively with biotin-coupled goat anti-rabbit Ig, with a complex of avidin/peroxidase-coupled biotin, and with the peroxidase substrate diaminobenzidine.
Generation and analysis of fl-galactosidase-C3 fusion proteins
Individual colonies of Y1089 recombinant lysogen were inoculated into 10 ml of Luria-Bertani medium (LB) and grown for 3 h at 37°C with good agitation. After the addition of 100 ml of 100 mM-isopropyl thio-/J-D-galactoside (IPTG), the culture was incubated overnight at 37 'C. The cells were harvested by centrifugation in a Beckman JAIO rotor at 5000 rev./min for 5 min at 30 'C. The cells were resuspended in 1 ml of 0.2 M-Tris/HCl (pH 7.5)/0.2 M-NaCl/l mM-EDTA/5 % (v/v) glycerol/ 1 mM-phenylmethanesulphonyl fluoride (PMSF)/1 mmdithiothreitol (DTT) and frozen at -70 'C. After thawing the samples and addition of 1 % SDS they were centrifuged in an Eppendorf centrifuge for 20 min. The supernatant was transferred to 12 ml conical glass tubes and 4 ml of ice-cold acetone was added to precipitate the proteins. After 2 h at -20 'C the proteins were pelleted by centrifugation at 5000 g, the pellet was resuspended in electrophoresis sample buffer, boiled, and an aliquot was analysed by SDS/PAGE. Duplicate gels were prepared. One was stained with Coomassie Blue to detect fusionprotein expression and the other was processed for immunoblotting. The electrophoresis was carried out in 12.5 0/o gels on a Phast System apparatus (Pharmacia AB) according to the manufacturer's recommendations. The transfer to nitrocellulose membranes was achieved by passive diffusion at 70 'C for 30 min. After the transfer the nitrocellulose membrane was incubated in 1 %o (w/v) BSA in PBS for 30 min, followed by incubation for 60 min with the different anti-C3 antibodies. Bound polyclonal antibody was detected by biotinylated goat anti-rabbit Ig antibody followed by streptavidin-HRP conjugate, and bound anti-C3 mAb was detected by biotin-conjugated sheep anti-mouse Ig followed by streptavidin-biotin-HRP complexes.
cDNA sequencing DNA from each clone was digested with Mlu (Grossberger, 1987) , and the fragment containing the cloning site was recovered by binding to glass beads (Vogelstein & Gillespie, 1979 Fig. 1 . Reactivity of the affinity-purified rabbit anti-C3 antibodies with C3 fragments and fusion proteins Affinity-purified rabbit anti-C3(D) antibodies (specific for achain) were tested for binding to the fusion proteins. The E. coli extracts were subjected to SDS/PAGE, followed by Westernblot analysis employing the polyclonal antibody. In Fig. 2 the binding of the affinity purified anti-C3 antibodies is shown, and the binding reactivity of the anti-C3 antibodies to each clone was scored based on intensity. The anti-ovalbumin antibodies did not bind to any of the C3 fusion proteins (results not shown).
In Fig. 1 the score of the binding for each protein is graphically presented and shows that the strongest binding was to proteins corresponding to the C-terminal half of the -40 kDa subunit of C3c, i.e., proteins C105 (3+), C121 (3±), C122 (2+) and C123 (3+). In contrast, no binding was observed to the protein Xl 22.
The antibodies did also bind to different clones in the C3d domain, i.e. C145 (I1+), C104 (2+), C117 (1+) and C135 (2+).
To establish whether the affinity-purified anti-C3 antibodies bound to epitopes that are expressed by bound or soluble C3 fragments, the antibody preparation was preincubated with mixtures of equal amounts of soluble C3b and iC3b or EAC3b and EAC3bi. In Fig. 3 Fig. 4 shows that mAb 7D326.1 and 7D331.1 were inhibited by EAC3b and EAC3bi. MAb 7D326. 1 was also inhibited by fluid-phase iC3b, but to get a similar inhibition to that of EAC3bi, a 50-fold higher dose of fluid-phase iC3b was required. 7D9.2 was inhibited exclusively by EAC3d cells. Unlike these three antibodies, 4SD1 1. and 4SD 18. 1 were not inhibited by any of the C3 fragments used. MAbs 4SD11.1, 4SD18.1, 7D9.2, 7D326.1 and 7D33 1.1 were tested for binding to the expressed fusion proteins. The fusion proteins were SDS/PAGE followed by Western-blot analysis. As Fig. 5 
DISCUSSION
The conformational changes in the molecule that accompany the proteolytic cleavage events during activation/inactivation of C3 and C3 fragments have been detected by using an assortment of chemical probes and spectral and solution scattering techniques (Molenaar et al., 1975; Isenman & Cooper, 1981; Pangburn et al., 1981; Isenman, 1983; Perkins & Sim, 1986) .
Although these techniques allowed the analysis of fluid-phase C3 fragments, technical difficulties have hampered a similar analysis of target surface-bound fragments. However, the use of mAbs has overcome these difficulties, and, in fact, been shown to be more sensitive in probing conformational changes in proteins than the low-resolution spectroscopic methods (Collawn et al., 1988) . By identifying the segment of the amino acid sequence that contains the antibody epitope, parts of the polypeptide chain involved in the conformational changes, or in forming surface structures of the molecule, have been recognized. Such studies of fluid-phase and bound C3 fragments have been performed in our and other laboratories using mAbs specific for neoantigenic epitopes in conjunction with overlapping synthetic peptides Burger et al., 1988; Alsenz et al., 1990; . These studies have identified regions in the C3a, iC3b, C3dg and C3d fragments of C3 which are associated with conformational changes that occur upon degradation of the C3 molecule.
Evidence that the conformation of C3 differs in the soluble, as compared with the bound, forms of C3 fragments is that C3(D) epitopes are exposed under these conditions (Nilsson & Nilsson, 1982; Nilsson et al., 1987 Nilsson et al., , 1989 . This is based on the observation that, during denaturation by SDS, exposure of C3(D) antigens by C3 or C3b is very well correlated to a profound conformational change detected by c.d. in the far-u.v. spectrum in these molecules. Under physiological conditions, C3(D) epitopes are expressed preferentially by bound C3 fragments and only to a small extent by the corresponding soluble molecule. By using mAbs and polyclonal antibodies specific for C3(D) epitopes for studies of the folding of the polypeptide chains of the bound C3 molecule, regions in the molecule involved in conformational changes associated with binding of C3 fragments to a target are identified.
In the present study both mAbs and polyclonal anti-C3 antibodies with C3(D) specificity, were used to localize epitopes on C3 specifically expressed by surface-bound and/or denatured fragments. These epitopes were mapped by using C3 fragments, expressed as,3-galactosidase fusion proteins, representing overlapping segments of the C3d fragment and the 40 kDa subunit of C3c. To distinguish between epitopes that were expressed by surface-bound and/or denatured C3 fragments, the antibodies were adsorbed with fluid-phase or erythrocyte-bound C3b/iC3b. The binding of the polyclonal anti-C3 antibodies (o-chainspecific) to fusion proteins C104 and C135 was inhibited by EAC3b/iC3b, but not with the corresponding fluid-phase C3 fragments. This indicated that the segments of C3 spanning residues 1117-1155 and 1234-1294 accommodate epitopes expressed specifically by both erythrocyte-bound C3b and iC3b fragments (Table 1) . Similarly, the binding of mAbs 7D326.1 and 7D33 1.1 to fusion protein X122 (spanning residues 1312-1404 of C3) was inhibited by EAC3b/iC3b and that of mAb 7D9.2 to C140 (residues 1312-1404) by EAC3d. None of the mAbs were inhibited by the corresponding fluid-phase C3 fragments. The remainder of the mAbs that recognized fusion proteins were not inhibited by any type of C3 fragment, indicating that the antibodies bound to epitopes that are hidden in physiological C3 fragments but expressed by denatured molecules. This study focuses on C3(D) epitopes located in the a-chain of C3. Combined with previous studies performed in our laboratories , C3(D) epitopes have been found to be distributed throughout the whole a-chain (Fig. 6) . As shown herein, epitopes which are exposed exclusively by denatured C3 or C3 fragments have been found in the C-terminal end of the polyp-eptide chain. Previous studies have demonstrated that a similar set of epitopes are found in the N-terminal end between amino acid residues 741 and 758 . By contrast, C3(D) epitopes eXpressed both by physiologically bound and denatured C3 fragments are found more in the centre of the primary sequence of the a-chain. In addition to those found in this study within the segments 1082-1155, 1234-1294 and 1312-1414, such epitopes were found between Arg929 and Ser946 using mAbs (7D264.6, 7D84.1) and synthetic peptides . The association between the location of the epitopes and the different functional sites in C3 is still unclear and requires further investigation. 
